www.newsmax.com
Prices for New US Drugs Rose 35 Percent in 2023
Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022‚ reflecting in part the industry's embrace of expensive therapies for rare diseases like muscular dystrophy‚ a Reuters analysis found. The median annual list price for a new drug was...